Study of Paroxetine and Vitamin C Effects on Blood Vessel Health After Preeclampsia in Women 18 to 45 Years

What this Trial Is About

This research investigates the relationship between preeclampsia, depression, and blood vessel health in women who have experienced both conditions. Preeclampsia is a pregnancy complication involving high blood pressure that increases the risk of heart disease and depression later in life. The study aims to understand why these risks are higher and whether depression treatments may improve blood vessel health after preeclampsia. Participants receive localized delivery of paroxetine hydrochloride and ascorbic acid to the skins small blood vessels using intradermal microdialysis. Four microdialysis fibers are placed in the forearm to deliver different treatments, including control fluids and combinations of the study drugs. Skin blood flow is measured during controlled heating protocols to assess blood vessel responses. All women follow the same procedures regardless of pregnancy or depression history. During the approximately 4-hour study visit, researchers measure how well the small blood vessels dilate, focusing on endothelium-dependent and nitric oxide-dependent responses using laser-Doppler flowmetry. These measurements help evaluate vascular function related to preeclampsia and depression. The total participation period is a single visit, with data collected on vascular responses to the study interventions and heating protocols.

Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia